Switzerland-based Hilo, a company focused on blood pressure monitoring, has secured about CHF 34M (nearly €36.39M) in Series B funding. The round was led by Earlybird Venture Capital and Wellington Partners.
Other participants include Kfund, naturalX Health Ventures, and existing investors Khosla Ventures, Molten Ventures, redalpine, Verve Ventures, and Translink Capital.
Transform your health with monitoring and personalised insights
Hilo, formerly known as Aktiia, was founded in 2018 to change how blood pressure is measured and managed. The company aims to help 100 million people control their blood pressure by 2032.
Hilo has created the first continuous blood pressure monitor, providing new data for both doctors and patients.
The company’s technology is based on 15 years of research by founders Mattia Bertschi and Josep Sola at the Swiss Centre for Electronics and Microtechnology (CSEM), marking the first major advancement in hypertension management in over two decades.
Hilo operates as a digital health platform, focusing on building a large database to assist physicians in diagnosing and treating patients.
The company expanded from 20 employees in Switzerland to 60 people globally in the past year. Currently, it operates remotely in the US and Europe, with flexible arrangements and offices in Switzerland.
Capital utilisation
Hilo is working toward a system where blood pressure is measured more often and more easily, based on the idea that frequent measurement supports better management. Existing methods rely mostly on cuffs, which limit how often people check their blood pressure. Hilo is working to change this.
The company will use the funds to expand the availability of its cuffless blood pressure monitoring tools, build partnerships with enterprise and healthcare groups, develop tools that use optical methods and phone cameras, and continue research and studies focused on blood pressure.
The company is also looking to increase its team and is currently hiring.
Aktiia rebrands as Hilo
Last month, Aktiia announced its rebranding to Hilo. The change marks a new phase in the company’s work to support health through ongoing blood pressure tracking.
While the name and visual identity are new, Hilo will continue to offer the same monitoring tools and data services.
The company remains focused on its mission to help people manage blood pressure, using technology and analytics to support this goal. The rebrand reflects a continued commitment to users and long-term health efforts.
01
These are the top UK-based PR agencies for startups and scale-ups in 2025